138 related articles for article (PubMed ID: 26226779)
1. [Myxoinflammatory fibroblastic sarcoma: clinicopathologic and immunohistochemical analysis].
Shelekhova KV
Arkh Patol; 2015; 77(3):30-36. PubMed ID: 26226779
[TBL] [Abstract][Full Text] [Related]
2. [Myxoinflammatory fibroblastic sarcoma: a clinicopathologic study of 6 cases with review of literature].
Xiang H; Shi XL; Li QX; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):94-8. PubMed ID: 21426804
[TBL] [Abstract][Full Text] [Related]
3. Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysis.
Kovarik CL; Barrett T; Auerbach A; Cassarino DS
J Cutan Pathol; 2008 Feb; 35(2):192-6. PubMed ID: 18190444
[TBL] [Abstract][Full Text] [Related]
4. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
5. High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases.
Michal M; Kazakov DV; Hadravský L; Kinkor Z; Kuroda N; Michal M
Ann Diagn Pathol; 2015 Jun; 19(3):157-63. PubMed ID: 25886867
[TBL] [Abstract][Full Text] [Related]
6. Myxoinflammatory fibroblastic sarcoma with areas resembling hemosiderotic fibrolipomatous tumor: a rare case indicating proximity between the two tumors.
Rekhi B; Adamane S
Indian J Pathol Microbiol; 2014; 57(4):647-8. PubMed ID: 25308033
[No Abstract] [Full Text] [Related]
7. [Myxoinflammatory fibroblastic sarcoma: report of a case].
Li WH; Zhang JM
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):57-8. PubMed ID: 20388404
[No Abstract] [Full Text] [Related]
8. [Leiomyosarcoma with prominent osteoclast-like giant cells: a clinicopathologic analysis of 7 cases and review of literature].
Li Y; Xu XL; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):363-7. PubMed ID: 21914342
[TBL] [Abstract][Full Text] [Related]
9. [Interdigitating dendritic cell sarcoma/tumor: a clinicopathologic study].
Pan M; Gong Q; Fan Q; Zhang Z; Li Y; Wang C
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):99-102. PubMed ID: 24742569
[TBL] [Abstract][Full Text] [Related]
10. Acral myxoinflammatory fibroblastic sarcomas: are they all low-grade neoplasms?
Hassanein AM; Atkinson SP; Al-Quran SZ; Jain SM; Reith JD
J Cutan Pathol; 2008 Feb; 35(2):186-91. PubMed ID: 18190443
[TBL] [Abstract][Full Text] [Related]
11. Myxoinflammatory fibroblastic sarcoma in children and adolescents: clinicopathologic aspects of a rare neoplasm.
Weiss VL; Antonescu CR; Alaggio R; Cates JM; Gaskin D; Stefanovici C; Coffin CM
Pediatr Dev Pathol; 2013; 16(6):425-31. PubMed ID: 23919754
[TBL] [Abstract][Full Text] [Related]
12. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
Wangsiricharoen S; Ali SZ; Wakely PE
J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
[TBL] [Abstract][Full Text] [Related]
13. Myxoinflammatory fibroblastic sarcoma: a tumor not restricted to acral sites.
Jurcić V; Zidar A; Montiel MD; Frković-Grazio S; Nayler SJ; Cooper K; Suster S; Lamovec J
Ann Diagn Pathol; 2002 Oct; 6(5):272-80. PubMed ID: 12376919
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.
Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M
Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209
[TBL] [Abstract][Full Text] [Related]
15. Acral myxoinflammatory fibroblastic sarcomas: MRI findings in four cases.
Narváez JA; Martinez S; Dodd LG; Brigman BE
AJR Am J Roentgenol; 2007 May; 188(5):1302-5. PubMed ID: 17449774
[TBL] [Abstract][Full Text] [Related]
16. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
Antonescu CR; Zhang L; Nielsen GP; Rosenberg AE; Dal Cin P; Fletcher CD
Genes Chromosomes Cancer; 2011 Oct; 50(10):757-64. PubMed ID: 21717526
[TBL] [Abstract][Full Text] [Related]
17. Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature.
Sakaki M; Hirokawa M; Wakatsuki S; Sano T; Endo K; Fujii Y; Ikeda T; Kawaguchi S; Hirose T; Hasegawa T
Virchows Arch; 2003 Jan; 442(1):25-30. PubMed ID: 12536311
[TBL] [Abstract][Full Text] [Related]
18. Myxoinflammatory fibroblastic sarcoma in an unreported area (groin).
Bar-Meir E; Fridman E; Zilinsky I; Orenstein A; Winkler E
J Cutan Pathol; 2007 Mar; 34(3):276-80. PubMed ID: 17302613
[TBL] [Abstract][Full Text] [Related]
19. The t(1;10)(p22;q24) TGFBR3/MGEA5 Translocation in Pleomorphic Hyalinizing Angiectatic Tumor, Myxoinflammatory Fibroblastic Sarcoma, and Hemosiderotic Fibrolipomatous Tumor.
Liu H; Sukov WR; Ro JY
Arch Pathol Lab Med; 2019 Feb; 143(2):212-221. PubMed ID: 29979612
[TBL] [Abstract][Full Text] [Related]
20. [Malignant granular cell tumor: a clinicopathologic analysis of 10 cases with review of literature].
Wang J; Zhu XZ; Zhang RY
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):497-502. PubMed ID: 15634442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
